|Bid||0.00 x 1200|
|Ask||0.00 x 1400|
|Day's Range||34.76 - 35.28|
|52 Week Range||30.40 - 37.90|
|Beta (5Y Monthly)||0.95|
|PE Ratio (TTM)||20.12|
|Forward Dividend & Yield||0.48 (1.33%)|
|Ex-Dividend Date||Jan 06, 2022|
|1y Target Est||N/A|
Vision-enhancement platform eSight has entered into a strategic partnership with Gentex Corp (NASDAQ: GNTX) to create assistive wearable technology for those with degenerative eyes diseases causing visual impairment. The financial terms were not disclosed. eSight uses a combination of hardware and software to enhance vision through a wearable device. eSight noted Gentex's capacity and design quality would enable mass-scale production for the next eSight device. "While medical scientists research
Gentex Corporation ( NASDAQ:GNTX ) stock is about to trade ex-dividend in 4 days. The ex-dividend date is one business...
The board of Gentex Corporation ( NASDAQ:GNTX ) has announced that it will pay a dividend of US$0.12 per share on the...